Dates: Monday 22nd - Thursday 25th April 2024 Time: 09:00-12:30 BST (on all 4 days) Location: Online via Zoom Presenters: Moira Verbelen (UCB), Jolyon Faria (AstraZeneca), Leo Souliotis (AstraZeneca) and Dan de Vassimon Manela (UCB).
Who is this event intended for? This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning.
What is the benefit of attending? Attendees will learn about a range of topics in machine learning, including practical sessions in R.
Cost
Early Bird PSI Members = £320+VAT Early Bird Non-Members = £430*+VAT *Please note: Early Bird prices expire at 17:00 on Friday 22nd March 2024.
Standard PSI Members = £360+VAT Standard Non-Members = £470*+VAT
*Please note: Non-Member rates include PSI membership until 31 Dec. 2024.
Four sessions will include ML foundation (including an introduction, data exploration for ML and dimensionality reduction and feature selection), Supervised learning (including support vector machines and model evaluation and interpretation), model optimization and unsupervised learning (including clustering) and advanced topics (including neural networks, deep learning and large language models).
Agenda
The examples covered in this Course will be in relation to Clinical Trials. For an overview of what will be covered across the four sessions, please see below. (Please be advised: this agenda may be subject to minor revisions)
Day 1: ML Foundation
Definitions and terminology
Key aspects of ML workflow
- Planning
- Pre-processing
- Data splitting
- Modelling, cross validation, hyperparameter estimation
- Evaluation
- Reporting
“ML in a day”. “Lightening” overview of simple ML workflow using R packages dplyr, caret, ggplot2 using logistic regression. This will be used as a starting point to exemplify key aspects of ML, and as a point of comparison for further methods such as Elastic Net (regularised regression), gradient boosting and neural networks
Common pitfalls and key considerations for using ML models in practice, and reviewing ML analyses, with a focus on the analysis of clinical trial data
Day 2: Supervised learning
What is supervised learning? Definitions and examples of scenario’s
Supervised learning workflow (short recap)
Supervised Algorithms:
- LASSO and Elastic Net
- Decision trees and Random Forest
- Support Vector Machines
Evaluation and interpretation of these algorithms
Practical session in R: Application of above methods in caret
Day 3: Unsupervised learning (including clustering)
Definitions and comparison to supervised learning
K-means, PCA, Non-linear approaches such as tSNE
Worked examples in R
Day 4: Neural Networks and Deep Learning
DEMO: ML in SAS
- How to use R ML from SAS Viya
- How to use no-code/low-code ML
- How to use SAS ML procs in R Studio
Introduction to neural networks and basic architectures
Deep learning, Large Language models, Computer Vision
Discussion of Machine Learning vs Statistics: what are the differences, how much to they overlap, when to use what
Speaker details
Speaker
Biography
Moira Verbelen
Moira Verbelen is Head of Machine Learning, AI and Data at UCB, and is passionate about adopting and implementing innovative AI methods in pharmaceutical research, in particular delivering AI solutions throughout all phases of clinical development. With a background bridging Pharmaceutical Sciences and Biostatistics, Moira holds a PhD from King’s College London, specializing in Machine Learning applied to Pharmacogenetics.
Jolyon Faria
Jolyon Faria works within the LASER Team within Oncology Data Science at AstraZeneca. He is aligned to the Lung cancer portfolio and his role is to perform retrospective analyses of AZ clinical trials and relevant multimodal data, with a focus on Statistics and Machine Learning, to inform the AZ Strategy for instance for PhIII Investment Decisions. He has a background in Biology: PhD (Univ. Leeds);
Postdoc (Princeton Univ.), and Applied Statistics: (MSc Univ. Oxford) and is a Chartered Statistician (CSTAT; Royal Statistical Society, UK).
Leo Souliotis
Leo Souliotis is part of the LASER team within the Oncology Data Science at AstraZeneca.
His role includes performing statistical and ML analyses in Lung studies, focusing on multi-study analysis in the Lung space. He is also leading an internal course on how
to use Python for Data Analysis. He is a Data Camp instructor, after developing the “Efficient Python coding in pandas ". He has a background in Statistics: MSc (Imperial
College London), PhD (University of Warwick).
Dan de Vassimon Manela
Dan de Vassimon Manela is a Machine Learning R&D and Innovation Lead at UCB and is interested in using Probabilistic Machine Learning methods to solve clinical problems across the pharmaceutical development chain. He has a background in Physics (BA, MSc Cambridge) and Statistical Machine Learning (MSci UCL).
Scientific Meetings
PSI Training Course: Introduction to Machine Learning
Dates: Monday 22nd - Thursday 25th April 2024 Time: 09:00-12:30 BST (on all 4 days) Location: Online via Zoom Presenters: Moira Verbelen (UCB), Jolyon Faria (AstraZeneca), Leo Souliotis (AstraZeneca) and Dan de Vassimon Manela (UCB).
Who is this event intended for? This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning.
What is the benefit of attending? Attendees will learn about a range of topics in machine learning, including practical sessions in R.
Cost
Early Bird PSI Members = £320+VAT Early Bird Non-Members = £430*+VAT *Please note: Early Bird prices expire at 17:00 on Friday 22nd March 2024.
Standard PSI Members = £360+VAT Standard Non-Members = £470*+VAT
*Please note: Non-Member rates include PSI membership until 31 Dec. 2024.
Four sessions will include ML foundation (including an introduction, data exploration for ML and dimensionality reduction and feature selection), Supervised learning (including support vector machines and model evaluation and interpretation), model optimization and unsupervised learning (including clustering) and advanced topics (including neural networks, deep learning and large language models).
Agenda
The examples covered in this Course will be in relation to Clinical Trials. For an overview of what will be covered across the four sessions, please see below. (Please be advised: this agenda may be subject to minor revisions)
Day 1: ML Foundation
Definitions and terminology
Key aspects of ML workflow
- Planning
- Pre-processing
- Data splitting
- Modelling, cross validation, hyperparameter estimation
- Evaluation
- Reporting
“ML in a day”. “Lightening” overview of simple ML workflow using R packages dplyr, caret, ggplot2 using logistic regression. This will be used as a starting point to exemplify key aspects of ML, and as a point of comparison for further methods such as Elastic Net (regularised regression), gradient boosting and neural networks
Common pitfalls and key considerations for using ML models in practice, and reviewing ML analyses, with a focus on the analysis of clinical trial data
Day 2: Supervised learning
What is supervised learning? Definitions and examples of scenario’s
Supervised learning workflow (short recap)
Supervised Algorithms:
- LASSO and Elastic Net
- Decision trees and Random Forest
- Support Vector Machines
Evaluation and interpretation of these algorithms
Practical session in R: Application of above methods in caret
Day 3: Unsupervised learning (including clustering)
Definitions and comparison to supervised learning
K-means, PCA, Non-linear approaches such as tSNE
Worked examples in R
Day 4: Neural Networks and Deep Learning
DEMO: ML in SAS
- How to use R ML from SAS Viya
- How to use no-code/low-code ML
- How to use SAS ML procs in R Studio
Introduction to neural networks and basic architectures
Deep learning, Large Language models, Computer Vision
Discussion of Machine Learning vs Statistics: what are the differences, how much to they overlap, when to use what
Speaker details
Speaker
Biography
Moira Verbelen
Moira Verbelen is Head of Machine Learning, AI and Data at UCB, and is passionate about adopting and implementing innovative AI methods in pharmaceutical research, in particular delivering AI solutions throughout all phases of clinical development. With a background bridging Pharmaceutical Sciences and Biostatistics, Moira holds a PhD from King’s College London, specializing in Machine Learning applied to Pharmacogenetics.
Jolyon Faria
Jolyon Faria works within the LASER Team within Oncology Data Science at AstraZeneca. He is aligned to the Lung cancer portfolio and his role is to perform retrospective analyses of AZ clinical trials and relevant multimodal data, with a focus on Statistics and Machine Learning, to inform the AZ Strategy for instance for PhIII Investment Decisions. He has a background in Biology: PhD (Univ. Leeds);
Postdoc (Princeton Univ.), and Applied Statistics: (MSc Univ. Oxford) and is a Chartered Statistician (CSTAT; Royal Statistical Society, UK).
Leo Souliotis
Leo Souliotis is part of the LASER team within the Oncology Data Science at AstraZeneca.
His role includes performing statistical and ML analyses in Lung studies, focusing on multi-study analysis in the Lung space. He is also leading an internal course on how
to use Python for Data Analysis. He is a Data Camp instructor, after developing the “Efficient Python coding in pandas ". He has a background in Statistics: MSc (Imperial
College London), PhD (University of Warwick).
Dan de Vassimon Manela
Dan de Vassimon Manela is a Machine Learning R&D and Innovation Lead at UCB and is interested in using Probabilistic Machine Learning methods to solve clinical problems across the pharmaceutical development chain. He has a background in Physics (BA, MSc Cambridge) and Statistical Machine Learning (MSci UCL).
Training Courses
PSI Training Course: Introduction to Machine Learning
Dates: Monday 22nd - Thursday 25th April 2024 Time: 09:00-12:30 BST (on all 4 days) Location: Online via Zoom Presenters: Moira Verbelen (UCB), Jolyon Faria (AstraZeneca), Leo Souliotis (AstraZeneca) and Dan de Vassimon Manela (UCB).
Who is this event intended for? This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning.
What is the benefit of attending? Attendees will learn about a range of topics in machine learning, including practical sessions in R.
Cost
Early Bird PSI Members = £320+VAT Early Bird Non-Members = £430*+VAT *Please note: Early Bird prices expire at 17:00 on Friday 22nd March 2024.
Standard PSI Members = £360+VAT Standard Non-Members = £470*+VAT
*Please note: Non-Member rates include PSI membership until 31 Dec. 2024.
Four sessions will include ML foundation (including an introduction, data exploration for ML and dimensionality reduction and feature selection), Supervised learning (including support vector machines and model evaluation and interpretation), model optimization and unsupervised learning (including clustering) and advanced topics (including neural networks, deep learning and large language models).
Agenda
The examples covered in this Course will be in relation to Clinical Trials. For an overview of what will be covered across the four sessions, please see below. (Please be advised: this agenda may be subject to minor revisions)
Day 1: ML Foundation
Definitions and terminology
Key aspects of ML workflow
- Planning
- Pre-processing
- Data splitting
- Modelling, cross validation, hyperparameter estimation
- Evaluation
- Reporting
“ML in a day”. “Lightening” overview of simple ML workflow using R packages dplyr, caret, ggplot2 using logistic regression. This will be used as a starting point to exemplify key aspects of ML, and as a point of comparison for further methods such as Elastic Net (regularised regression), gradient boosting and neural networks
Common pitfalls and key considerations for using ML models in practice, and reviewing ML analyses, with a focus on the analysis of clinical trial data
Day 2: Supervised learning
What is supervised learning? Definitions and examples of scenario’s
Supervised learning workflow (short recap)
Supervised Algorithms:
- LASSO and Elastic Net
- Decision trees and Random Forest
- Support Vector Machines
Evaluation and interpretation of these algorithms
Practical session in R: Application of above methods in caret
Day 3: Unsupervised learning (including clustering)
Definitions and comparison to supervised learning
K-means, PCA, Non-linear approaches such as tSNE
Worked examples in R
Day 4: Neural Networks and Deep Learning
DEMO: ML in SAS
- How to use R ML from SAS Viya
- How to use no-code/low-code ML
- How to use SAS ML procs in R Studio
Introduction to neural networks and basic architectures
Deep learning, Large Language models, Computer Vision
Discussion of Machine Learning vs Statistics: what are the differences, how much to they overlap, when to use what
Speaker details
Speaker
Biography
Moira Verbelen
Moira Verbelen is Head of Machine Learning, AI and Data at UCB, and is passionate about adopting and implementing innovative AI methods in pharmaceutical research, in particular delivering AI solutions throughout all phases of clinical development. With a background bridging Pharmaceutical Sciences and Biostatistics, Moira holds a PhD from King’s College London, specializing in Machine Learning applied to Pharmacogenetics.
Jolyon Faria
Jolyon Faria works within the LASER Team within Oncology Data Science at AstraZeneca. He is aligned to the Lung cancer portfolio and his role is to perform retrospective analyses of AZ clinical trials and relevant multimodal data, with a focus on Statistics and Machine Learning, to inform the AZ Strategy for instance for PhIII Investment Decisions. He has a background in Biology: PhD (Univ. Leeds);
Postdoc (Princeton Univ.), and Applied Statistics: (MSc Univ. Oxford) and is a Chartered Statistician (CSTAT; Royal Statistical Society, UK).
Leo Souliotis
Leo Souliotis is part of the LASER team within the Oncology Data Science at AstraZeneca.
His role includes performing statistical and ML analyses in Lung studies, focusing on multi-study analysis in the Lung space. He is also leading an internal course on how
to use Python for Data Analysis. He is a Data Camp instructor, after developing the “Efficient Python coding in pandas ". He has a background in Statistics: MSc (Imperial
College London), PhD (University of Warwick).
Dan de Vassimon Manela
Dan de Vassimon Manela is a Machine Learning R&D and Innovation Lead at UCB and is interested in using Probabilistic Machine Learning methods to solve clinical problems across the pharmaceutical development chain. He has a background in Physics (BA, MSc Cambridge) and Statistical Machine Learning (MSci UCL).
Journal Club
PSI Training Course: Introduction to Machine Learning
Dates: Monday 22nd - Thursday 25th April 2024 Time: 09:00-12:30 BST (on all 4 days) Location: Online via Zoom Presenters: Moira Verbelen (UCB), Jolyon Faria (AstraZeneca), Leo Souliotis (AstraZeneca) and Dan de Vassimon Manela (UCB).
Who is this event intended for? This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning.
What is the benefit of attending? Attendees will learn about a range of topics in machine learning, including practical sessions in R.
Cost
Early Bird PSI Members = £320+VAT Early Bird Non-Members = £430*+VAT *Please note: Early Bird prices expire at 17:00 on Friday 22nd March 2024.
Standard PSI Members = £360+VAT Standard Non-Members = £470*+VAT
*Please note: Non-Member rates include PSI membership until 31 Dec. 2024.
Four sessions will include ML foundation (including an introduction, data exploration for ML and dimensionality reduction and feature selection), Supervised learning (including support vector machines and model evaluation and interpretation), model optimization and unsupervised learning (including clustering) and advanced topics (including neural networks, deep learning and large language models).
Agenda
The examples covered in this Course will be in relation to Clinical Trials. For an overview of what will be covered across the four sessions, please see below. (Please be advised: this agenda may be subject to minor revisions)
Day 1: ML Foundation
Definitions and terminology
Key aspects of ML workflow
- Planning
- Pre-processing
- Data splitting
- Modelling, cross validation, hyperparameter estimation
- Evaluation
- Reporting
“ML in a day”. “Lightening” overview of simple ML workflow using R packages dplyr, caret, ggplot2 using logistic regression. This will be used as a starting point to exemplify key aspects of ML, and as a point of comparison for further methods such as Elastic Net (regularised regression), gradient boosting and neural networks
Common pitfalls and key considerations for using ML models in practice, and reviewing ML analyses, with a focus on the analysis of clinical trial data
Day 2: Supervised learning
What is supervised learning? Definitions and examples of scenario’s
Supervised learning workflow (short recap)
Supervised Algorithms:
- LASSO and Elastic Net
- Decision trees and Random Forest
- Support Vector Machines
Evaluation and interpretation of these algorithms
Practical session in R: Application of above methods in caret
Day 3: Unsupervised learning (including clustering)
Definitions and comparison to supervised learning
K-means, PCA, Non-linear approaches such as tSNE
Worked examples in R
Day 4: Neural Networks and Deep Learning
DEMO: ML in SAS
- How to use R ML from SAS Viya
- How to use no-code/low-code ML
- How to use SAS ML procs in R Studio
Introduction to neural networks and basic architectures
Deep learning, Large Language models, Computer Vision
Discussion of Machine Learning vs Statistics: what are the differences, how much to they overlap, when to use what
Speaker details
Speaker
Biography
Moira Verbelen
Moira Verbelen is Head of Machine Learning, AI and Data at UCB, and is passionate about adopting and implementing innovative AI methods in pharmaceutical research, in particular delivering AI solutions throughout all phases of clinical development. With a background bridging Pharmaceutical Sciences and Biostatistics, Moira holds a PhD from King’s College London, specializing in Machine Learning applied to Pharmacogenetics.
Jolyon Faria
Jolyon Faria works within the LASER Team within Oncology Data Science at AstraZeneca. He is aligned to the Lung cancer portfolio and his role is to perform retrospective analyses of AZ clinical trials and relevant multimodal data, with a focus on Statistics and Machine Learning, to inform the AZ Strategy for instance for PhIII Investment Decisions. He has a background in Biology: PhD (Univ. Leeds);
Postdoc (Princeton Univ.), and Applied Statistics: (MSc Univ. Oxford) and is a Chartered Statistician (CSTAT; Royal Statistical Society, UK).
Leo Souliotis
Leo Souliotis is part of the LASER team within the Oncology Data Science at AstraZeneca.
His role includes performing statistical and ML analyses in Lung studies, focusing on multi-study analysis in the Lung space. He is also leading an internal course on how
to use Python for Data Analysis. He is a Data Camp instructor, after developing the “Efficient Python coding in pandas ". He has a background in Statistics: MSc (Imperial
College London), PhD (University of Warwick).
Dan de Vassimon Manela
Dan de Vassimon Manela is a Machine Learning R&D and Innovation Lead at UCB and is interested in using Probabilistic Machine Learning methods to solve clinical problems across the pharmaceutical development chain. He has a background in Physics (BA, MSc Cambridge) and Statistical Machine Learning (MSci UCL).
Webinars
PSI Training Course: Introduction to Machine Learning
Dates: Monday 22nd - Thursday 25th April 2024 Time: 09:00-12:30 BST (on all 4 days) Location: Online via Zoom Presenters: Moira Verbelen (UCB), Jolyon Faria (AstraZeneca), Leo Souliotis (AstraZeneca) and Dan de Vassimon Manela (UCB).
Who is this event intended for? This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning.
What is the benefit of attending? Attendees will learn about a range of topics in machine learning, including practical sessions in R.
Cost
Early Bird PSI Members = £320+VAT Early Bird Non-Members = £430*+VAT *Please note: Early Bird prices expire at 17:00 on Friday 22nd March 2024.
Standard PSI Members = £360+VAT Standard Non-Members = £470*+VAT
*Please note: Non-Member rates include PSI membership until 31 Dec. 2024.
Four sessions will include ML foundation (including an introduction, data exploration for ML and dimensionality reduction and feature selection), Supervised learning (including support vector machines and model evaluation and interpretation), model optimization and unsupervised learning (including clustering) and advanced topics (including neural networks, deep learning and large language models).
Agenda
The examples covered in this Course will be in relation to Clinical Trials. For an overview of what will be covered across the four sessions, please see below. (Please be advised: this agenda may be subject to minor revisions)
Day 1: ML Foundation
Definitions and terminology
Key aspects of ML workflow
- Planning
- Pre-processing
- Data splitting
- Modelling, cross validation, hyperparameter estimation
- Evaluation
- Reporting
“ML in a day”. “Lightening” overview of simple ML workflow using R packages dplyr, caret, ggplot2 using logistic regression. This will be used as a starting point to exemplify key aspects of ML, and as a point of comparison for further methods such as Elastic Net (regularised regression), gradient boosting and neural networks
Common pitfalls and key considerations for using ML models in practice, and reviewing ML analyses, with a focus on the analysis of clinical trial data
Day 2: Supervised learning
What is supervised learning? Definitions and examples of scenario’s
Supervised learning workflow (short recap)
Supervised Algorithms:
- LASSO and Elastic Net
- Decision trees and Random Forest
- Support Vector Machines
Evaluation and interpretation of these algorithms
Practical session in R: Application of above methods in caret
Day 3: Unsupervised learning (including clustering)
Definitions and comparison to supervised learning
K-means, PCA, Non-linear approaches such as tSNE
Worked examples in R
Day 4: Neural Networks and Deep Learning
DEMO: ML in SAS
- How to use R ML from SAS Viya
- How to use no-code/low-code ML
- How to use SAS ML procs in R Studio
Introduction to neural networks and basic architectures
Deep learning, Large Language models, Computer Vision
Discussion of Machine Learning vs Statistics: what are the differences, how much to they overlap, when to use what
Speaker details
Speaker
Biography
Moira Verbelen
Moira Verbelen is Head of Machine Learning, AI and Data at UCB, and is passionate about adopting and implementing innovative AI methods in pharmaceutical research, in particular delivering AI solutions throughout all phases of clinical development. With a background bridging Pharmaceutical Sciences and Biostatistics, Moira holds a PhD from King’s College London, specializing in Machine Learning applied to Pharmacogenetics.
Jolyon Faria
Jolyon Faria works within the LASER Team within Oncology Data Science at AstraZeneca. He is aligned to the Lung cancer portfolio and his role is to perform retrospective analyses of AZ clinical trials and relevant multimodal data, with a focus on Statistics and Machine Learning, to inform the AZ Strategy for instance for PhIII Investment Decisions. He has a background in Biology: PhD (Univ. Leeds);
Postdoc (Princeton Univ.), and Applied Statistics: (MSc Univ. Oxford) and is a Chartered Statistician (CSTAT; Royal Statistical Society, UK).
Leo Souliotis
Leo Souliotis is part of the LASER team within the Oncology Data Science at AstraZeneca.
His role includes performing statistical and ML analyses in Lung studies, focusing on multi-study analysis in the Lung space. He is also leading an internal course on how
to use Python for Data Analysis. He is a Data Camp instructor, after developing the “Efficient Python coding in pandas ". He has a background in Statistics: MSc (Imperial
College London), PhD (University of Warwick).
Dan de Vassimon Manela
Dan de Vassimon Manela is a Machine Learning R&D and Innovation Lead at UCB and is interested in using Probabilistic Machine Learning methods to solve clinical problems across the pharmaceutical development chain. He has a background in Physics (BA, MSc Cambridge) and Statistical Machine Learning (MSci UCL).
Careers Meetings
PSI Training Course: Introduction to Machine Learning
Dates: Monday 22nd - Thursday 25th April 2024 Time: 09:00-12:30 BST (on all 4 days) Location: Online via Zoom Presenters: Moira Verbelen (UCB), Jolyon Faria (AstraZeneca), Leo Souliotis (AstraZeneca) and Dan de Vassimon Manela (UCB).
Who is this event intended for? This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning.
What is the benefit of attending? Attendees will learn about a range of topics in machine learning, including practical sessions in R.
Cost
Early Bird PSI Members = £320+VAT Early Bird Non-Members = £430*+VAT *Please note: Early Bird prices expire at 17:00 on Friday 22nd March 2024.
Standard PSI Members = £360+VAT Standard Non-Members = £470*+VAT
*Please note: Non-Member rates include PSI membership until 31 Dec. 2024.
Four sessions will include ML foundation (including an introduction, data exploration for ML and dimensionality reduction and feature selection), Supervised learning (including support vector machines and model evaluation and interpretation), model optimization and unsupervised learning (including clustering) and advanced topics (including neural networks, deep learning and large language models).
Agenda
The examples covered in this Course will be in relation to Clinical Trials. For an overview of what will be covered across the four sessions, please see below. (Please be advised: this agenda may be subject to minor revisions)
Day 1: ML Foundation
Definitions and terminology
Key aspects of ML workflow
- Planning
- Pre-processing
- Data splitting
- Modelling, cross validation, hyperparameter estimation
- Evaluation
- Reporting
“ML in a day”. “Lightening” overview of simple ML workflow using R packages dplyr, caret, ggplot2 using logistic regression. This will be used as a starting point to exemplify key aspects of ML, and as a point of comparison for further methods such as Elastic Net (regularised regression), gradient boosting and neural networks
Common pitfalls and key considerations for using ML models in practice, and reviewing ML analyses, with a focus on the analysis of clinical trial data
Day 2: Supervised learning
What is supervised learning? Definitions and examples of scenario’s
Supervised learning workflow (short recap)
Supervised Algorithms:
- LASSO and Elastic Net
- Decision trees and Random Forest
- Support Vector Machines
Evaluation and interpretation of these algorithms
Practical session in R: Application of above methods in caret
Day 3: Unsupervised learning (including clustering)
Definitions and comparison to supervised learning
K-means, PCA, Non-linear approaches such as tSNE
Worked examples in R
Day 4: Neural Networks and Deep Learning
DEMO: ML in SAS
- How to use R ML from SAS Viya
- How to use no-code/low-code ML
- How to use SAS ML procs in R Studio
Introduction to neural networks and basic architectures
Deep learning, Large Language models, Computer Vision
Discussion of Machine Learning vs Statistics: what are the differences, how much to they overlap, when to use what
Speaker details
Speaker
Biography
Moira Verbelen
Moira Verbelen is Head of Machine Learning, AI and Data at UCB, and is passionate about adopting and implementing innovative AI methods in pharmaceutical research, in particular delivering AI solutions throughout all phases of clinical development. With a background bridging Pharmaceutical Sciences and Biostatistics, Moira holds a PhD from King’s College London, specializing in Machine Learning applied to Pharmacogenetics.
Jolyon Faria
Jolyon Faria works within the LASER Team within Oncology Data Science at AstraZeneca. He is aligned to the Lung cancer portfolio and his role is to perform retrospective analyses of AZ clinical trials and relevant multimodal data, with a focus on Statistics and Machine Learning, to inform the AZ Strategy for instance for PhIII Investment Decisions. He has a background in Biology: PhD (Univ. Leeds);
Postdoc (Princeton Univ.), and Applied Statistics: (MSc Univ. Oxford) and is a Chartered Statistician (CSTAT; Royal Statistical Society, UK).
Leo Souliotis
Leo Souliotis is part of the LASER team within the Oncology Data Science at AstraZeneca.
His role includes performing statistical and ML analyses in Lung studies, focusing on multi-study analysis in the Lung space. He is also leading an internal course on how
to use Python for Data Analysis. He is a Data Camp instructor, after developing the “Efficient Python coding in pandas ". He has a background in Statistics: MSc (Imperial
College London), PhD (University of Warwick).
Dan de Vassimon Manela
Dan de Vassimon Manela is a Machine Learning R&D and Innovation Lead at UCB and is interested in using Probabilistic Machine Learning methods to solve clinical problems across the pharmaceutical development chain. He has a background in Physics (BA, MSc Cambridge) and Statistical Machine Learning (MSci UCL).
Upcoming Events
PSI Introduction to Industry Training (ITIT) Course - 2025/2026
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
PSI Book Club Webinar: Atomic Habits - The Science of Getting Your Act Together
The book club’s usual focus is to read and discuss professional development books. In this short format event you can more easily develop you career without the commitment of reading the whole book - simply listen to the 1-hour long podcast before joining the interactive session on 21 May.
PSI Webinar: Methods and tools integrating clinical trial evidence with historical or real-world data, Bayesian borrowing, and causal inference
This webinar is organised by the RWD SIG and the Historical Data SIG. We will review recent methods, applications, and tools of integrating subject-level-data from clinical trial with external data using Bayesian methods and/or causal inference methods.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Webinar: Applying the Estimand Framework to Clinical Pharmacology Trials with a Case Study in Bioequivalance
This will be a 45 minute webinar which will explain the topic presented in the published paper, ‘Applying the Estimand Framework to Clinical Pharmacology Trials with a Case Study in Bioequivalance’. There will be 15 minutes for a panel Q&A with some of the authors following the presentation.
PSI Webinar: Methodology and first results of the iRISE (improving Reproducibility In SciencE) consortium
This 1-hour webinar will be an opportunity to hear about the methodology and first results of the iRISE consortium. iRISE is working towards a better understanding of reproducibility and the interventions that work to improve it. At the end of the presentation there will also be the opportunity to ask questions.
One-day PSI/PHUSE Event: Change Management for Moving to R/Open-Source
This one-day event focuses on the comprehensive management of transitioning to R/Open-Source, addressing the challenges and providing actionable insights. Attendees will participate in sessions covering essential topics such as training best practices, creating strategic plans, making the case to senior management, and managing both statistical and programming aspects of the transition.
PSI Book Club - The Art of Explanation: How to Communicate with Clarity and Confidence
Develop your non-technical skills by reading The Art of Explanation by Ros Atkins and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply skills from the book in-between sessions.
This course is aimed at biostatisticians with no or some pediatric drug development experience who are interested to further their understanding. We will give you an introduction to the pediatric drug development landscape. This will include identifying the key regulations and processes governing pediatric development, a discussion on the needs and challenges when conducting pediatric research and a focus on the ways to overcome these challenges from a statistical perspective.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
The program will feature insightful sessions led by distinguished invited speakers, alongside a poster session showcasing the latest advancements in the field. Further details will be provided.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This is an exciting, new opportunity for an experienced Statistician looking to take the next step in their career. Offered as a remote or hybrid position aligned with our site in Harrogate, North Yorkshire.
We use cookies to collect and analyse information on site performance and usage, to provide social media features and to enhance and customise content and advertisements.
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them. When categories than have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser.
Additionally you can see a list of cookies assigned to each category and detailed information in the cookie declaration.
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Amazon Web Services offers a broad set of global cloud-based products including compute, storage, databases, analytics, networking, mobile, developer tools, management tools, IoT, security, and enterprise applications.
Microsoft Azure is a cloud computing platform offering a wide range of services, including virtual machines, databases, and AI tools.
ARRAffinity
ARRAffinitySameSite
Preferences
Preference cookies enables the web site to remember information to customize how the web site looks or behaves for each user. This may include storing selected currency, region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Vimeo, Inc. is an American video hosting, sharing, services provider, and broadcaster. Vimeo focuses on the delivery of high-definition video across a range of devices.
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them. When categories than have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser.
Additionally you can see a list of cookies assigned to each category and detailed information in the cookie declaration.
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Necessary cookies
Name
Hostname
Vendor
Expiry
ARRAffinity
.psiweb.org
Session
This cookie is set by websites run on the Windows Azure cloud platform. It is used for load balancing to make sure the visitor page requests are routed to the same server in any browsing session.
ARRAffinitySameSite
.psiweb.org
Session
Used to distribute traffic to the website on several servers in order to optimize response times.
__cf_bm
.vimeo.com
Cloudflare, Inc.
1 hour
The __cf_bm cookie supports Cloudflare Bot Management by managing incoming traffic that matches criteria associated with bots. The cookie does not collect any personal data, and any information collected is subject to one-way encryption.
_cfuvid
.vimeo.com
Session
Used by Cloudflare WAF to distinguish individual users who share the same IP address and apply rate limits
__cf_bm
.glueup.com
Cloudflare, Inc.
1 hour
The __cf_bm cookie supports Cloudflare Bot Management by managing incoming traffic that matches criteria associated with bots. The cookie does not collect any personal data, and any information collected is subject to one-way encryption.
AWSALBTGCORS
psi.glueup.com
7 days
AWS Classic Load Balancer Cookie: Load Balancing Cookie: Used to map the session to the instance. Same value as AWSELB.
PHPSESSID
psi.glueup.com
Session
Cookie generated by applications based on the PHP language. This is a general purpose identifier used to maintain user session variables. It is normally a random generated number, how it is used can be specific to the site, but a good example is maintaining a logged-in status for a user between pages.
Used by CookieHub to store information about whether visitors have given or declined the use of cookie categories used on the site.
Preferences
Preference cookies enables the web site to remember information to customize how the web site looks or behaves for each user. This may include storing selected currency, region, language or color theme.
Preferences
Name
Hostname
Vendor
Expiry
vuid
.vimeo.com
400 days
These cookies are used by the Vimeo video player on websites.
AWSALBCORS
psi.glueup.com
7 days
Amazon Web Services cookie. This cookie enables us to allocate server traffic to make the user experience as smooth as possible. A so-called load balancer is used to determine which server currently has the best availability. The information generated cannot identify you as an individual.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.